LBRX
Lb Pharmaceuticals IncCompany with tickers: LBRX
CIK
1691082
CUSIP
50180M108
Shares Outstanding
28,676,652
Website
https://lbpharma.us
Investor Relations
https://ir.lbpharma.us/
13F Activity (30d)
8 filings
7 filers
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
No Compensation Data
No Summary Compensation Table has been imported from this company's proxy statements yet.
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Anna Eramo, M.D. | Chief Medical Officer | Resigned | 2026-06-10 |